The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Standardized definitions of molecular response in chronic myeloid leukemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kolb, H., Schattenberg, A., Goldman, J., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., & Niederwieser, D. (1995) · Blood · doi:10.1182/blood.v86.5.2041.bloodjournal8652041 · Cited by 1,934
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
Saglio, G., Kim, D.-W., Issaragrisil, S., le Coutre, P., Etienne, G., Lobo, C., Pasquini, R., Clark, R. E., Hochhaus, A., Hughes, T. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0912614 · Cited by 1,678
Self-citationDasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, H., Shah, N. P., Hochhaus, A., Cortes, J., Shah, S., Ayala, M., Moiraghi, B., Shen, Z., Mayer, J., Pasquini, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002315 · Cited by 1,589
Self-citationMahon, F.-X., Réa, D., Guilhot, J., Guilhot, F., Huguet, F., Nicolini, F., Legros, L., Charbonnier, A., Guerci, A., Varet, B., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70233-3 · Cited by 1,550
Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0779 · Cited by 1,291
Self-citationHughes, T. P., Kaeda, J., Branford, S., Rudzki, Z., Hochhaus, A., Hensley, M. L., Gathmann, I., Bolton, A. E., van Hoomissen, I. C., Goldman, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030513 · Cited by 1,218
Self-citationHughes, T. (2006) · Blood · doi:10.1182/blood-2006-01-0092 · Cited by 1,199
Graham, S. M., Jørgensen, H. G., Allan, E., Pearson, C., Alcorn, M. J., Richmond, L., & Holyoake, T. L. (2002) · Blood · doi:10.1182/blood.v99.1.319 · Cited by 1,181
Beillard, E., Pallisgaard, N., van der Velden, V. H. J., Bi, W., Dee, R., van der Schoot, E., Delabesse, E., Macintyre, E., Gottardi, E., Saglio, G., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403136 · Cited by 881
Self-citationDeininger, M., O'Brien, S. G., Guilhot, F., Goldman, J. M., Hochhaus, A., Hughes, T. P., Radich, J. P., Hatfield, A. K., Mone, M., Filian, J., et al. (2009) · Blood · doi:10.1182/blood.v114.22.1126.1126 · Cited by 616
Self-citationKantarjian, H. M., Shah, N. P., Cortes, J. E., Baccarani, M., Agarwal, M. B., Undurraga, M. S., Wang, J., Kassack Ipiña, J. J., Kim, D.-W., Ogura, M., et al. (2012) · Blood · doi:10.1182/blood-2011-08-376087 · Cited by 610
Self-citationKantarjian, H. M., Hochhaus, A., Saglio, G., De Souza, C., Flinn, I. W., Stenke, L., Goh, Y.-T., Rosti, G., Nakamae, H., Gallagher, N. J., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70201-7 · Cited by 513
Self-citationHughes, T. P., Hochhaus, A., Branford, S., Müller, M. C., Kaeda, J. S., Foroni, L., Druker, B. J., Guilhot, F., Larson, R. A., O'Brien, S. G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273979 · Cited by 489
Self-citationBranford, S., Fletcher, L., Cross, N. C. P., Müller, M. C., Hochhaus, A., Kim, D.-W., Radich, J. P., Saglio, G., Pane, F., Kamel-Reid, S., et al. (2008) · Blood · doi:10.1182/blood-2008-04-150680 · Cited by 388
Self-citationChronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
Bonifazi, F., de Vivo, A., Rosti, G., Guilhot, F., Guilhot, J., Trabacchi, E., Hehlmann, R., Hochhaus, A., Shepherd, P. C. A., Steegmann, J. L., et al. (2001) · Blood · doi:10.1182/blood.v98.10.3074 · Cited by 321
Self-citationDiscontinuation of imatinib therapy after achieving a molecular response
Cortes, J., O'Brien, S., & Kantarjian, H. (2004) · Blood · doi:10.1182/blood-2004-04-1335 · Cited by 280
Ross, D. M., Branford, S., Seymour, J. F., Schwarer, A. P., Arthur, C., Bartley, P. A., Slader, C., Field, C., Dang, P., Filshie, R. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.185 · Cited by 268
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Cortes, J. E., Jones, D., O'Brien, S., Jabbour, E., Konopleva, M., Ferrajoli, A., Kadia, T., Borthakur, G., Stigliano, D., Shan, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4896 · Cited by 244
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
Cortes, J. E., Jones, D., O'Brien, S., Jabbour, E., Ravandi, F., Koller, C., Borthakur, G., Walker, B., Zhao, W., Shan, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4920 · Cited by 241
Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
Rosti, G., Palandri, F., Castagnetti, F., Breccia, M., Levato, L., Gugliotta, G., Capucci, A., Cedrone, M., Fava, C., Intermesoli, T., et al. (2009) · Blood · doi:10.1182/blood-2009-07-232595 · Cited by 210
Self-citationHarmonization of molecular monitoring of CML therapy in Europe
Müller, M. C., Cross, N. C. P., Erben, P., Schenk, T., Hanfstein, B., Ernst, T., Hehlmann, R., Branford, S., Saglio, G., & Hochhaus, A. (2009) · Leukemia · doi:10.1038/leu.2009.168 · Cited by 208
Self-citationHochhaus, A., Reiter, A., Reichert, S. S., Emig, M., Kaeda, J., Schultheis, B., Berger, U., Shepherd, P. C. A., Allan, N. C., Hehlmann, R., et al. (2000) · Blood · doi:10.1182/blood.v95.1.62 · Cited by 181
Self-citationBurchert, A., Müller, M. C., Kostrewa, P., Erben, P., Bostel, T., Liebler, S., Hehlmann, R., Neubauer, A., & Hochhaus, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.5075 · Cited by 174
Self-citationWhite, H. E., Matejtschuk, P., Rigsby, P., Gabert, J., Lin, F., Lynn Wang, Y., Branford, S., Müller, M. C., Beaufils, N., Beillard, E., et al. (2010) · Blood · doi:10.1182/blood-2010-06-291641 · Cited by 159
Self-citationPacker, L., Rana, S., Hayward, R., O’Hare, T., Eide, C. A., Rebocho, A. P., Heidorn, S. J., Zabriskie, M. S., Niculescu‐Duvaz, I., Druker, B. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.11.004 · Cited by 125
Kumari, A., Brendel, C. A., Hochhaus, A., Neubauer, A., & Burchert, A. (2011) · Blood · doi:10.1182/blood-2010-08-303495 · Cited by 87
Self-citationSobrinho-Simões, M. A., Wilczek, V. J., Score, J., Cross, N. C. P., Apperley, J. F., & Melo, J. V. (2010) · Blood · doi:10.1182/blood-2009-11-255109 · Cited by 83
Self-citationSecond-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy
Kantarjian, H. M., Baccarani, M., Jabbour, E. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2922 · Cited by 54
Hughes, T. P., Hochhaus, A., Saglio, G. N., Kim, D., Jootar, S., le Coutre, P. D., Reiffers, J. J., Pasqüini, R., Lobo, C. L. D. C., Clark, R. E., et al. (2010) · Blood · doi:10.1182/blood.v116.21.207.207 · Cited by 47
Self-citationNair, R. R., Tolentino, J. H. G., Argilagos, R. F., Zhang, L., Pinilla-Ibarz, J. A., & Hazlehurst, L. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.12.002 · Cited by 37
Kantarjian, H. M., Kim, D.-W., Issaragrisil, S., Clark, R. E., Reiffers, J. J., Nicolini, F. E., Pasqüini, R., Kalaycio, M. E., Hughes, T. P., Hochhaus, A., et al. (2012) · Blood · doi:10.1182/blood.v120.21.1676.1676 · Cited by 37
Self-citation
Cited by
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M., Deininger, M. W., Rosti, G., Hochhaus, A., Soverini, S., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Guilhot, F., et al. (2013) · Blood · doi:10.1182/blood-2013-05-501569 · Cited by 1,987
Self-citationEuropean LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0776-2 · Cited by 1,547
Self-citationRoss, D. M., Branford, S., Seymour, J. F., Schwarer, A. P., Arthur, C., Yeung, D. T., Dang, P., Goyne, J. M., Slader, C., Filshie, R. J., et al. (2013) · Blood · doi:10.1182/blood-2013-02-483750 · Cited by 710
Etienne, G., Guilhot, J., Rea, D., Rigal-Huguet, F., Nicolini, F., Charbonnier, A., Guerci-Bresler, A., Legros, L., Varet, B., Gardembas, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.2914 · Cited by 496
Considerations for Digital PCR as an Accurate Molecular Diagnostic Tool
Huggett, J. F., Cowen, S., & Foy, C. A. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.221366 · Cited by 444
Metadata
- Authors
- Cross, N. C. P., White, H. E., Müller, M. C., Saglio, G., & Hochhaus, A.
- Venue
- Leukemia
- Published
- 2012-04-16
- Volume
- 26
- Issue
- 10
- Pages
- 2172-2175
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2074301005
- Cited by
- 378
- References
- 31
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.